Beyond Air, Inc.
XAIR
Rank in Stocks
#31263
Beyond Air, Inc. functions as a specialized entity involved in both the... Beyond Air, Inc. functions as a specialized entity involved in both the development of medical devices and biopharmaceutical solutions. A central part of its operations is the LungFit platform, an innovative system that generates and delivers nitric oxide. Within this platform, LungFit PH is currently available, used to address persistent pulmonary hypertension in infants. Furthermore, the company is advancing LungFit PRO, a product intended for various viral lung ailments like community-acquired viral pneumonia (including COVID-19) and bronchiolitis in hospital settings. It is also creating LungFit GO, which aims to treat nontuberculous mycobacteria infections. The organization adopted its current name, Beyond Air, Inc., in June 2019, having previously been known as AIT Therapeutics, Inc. Its headquarters are situated in Garden City, New York.
Share Price
$1.54
Last synced: 2026-11-20
Market Cap
$3.20M
Change (1 day)
-10.47%
Change (1 year)
-94.12%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Beyond Air, Inc. (XAIR)
Category
Healthcare
Operating Margin for Beyond Air, Inc. (XAIR)
Operating Margin as of November 2026 TTM: -321.65%
According to Beyond Air, Inc.'s latest financial reports, its current operating margin (TTM) is -321.65%. At the end of 2025 the company had an operating margin of -1,202.08%.
Operating Margin history for Beyond Air, Inc. from 2013 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -321.65% | -73.24% |
| 2025 | -1,202.08% | -77.89% |
| 2024 | -5,436.24% | 0.00% |
| 2023 | 0.00% | 0.00% |
| 2022 | 0.00% | -100.00% |
| 2021 | -2,544.56% | 94.97% |
| 2020 | -1,305.08% | 3,195.66% |
| 2019 | -39.60% | 0.00% |
| 2018 | 0.00% | 0.00% |
| 2016 | 0.00% | 0.00% |
| 2015 | 0.00% | 0.00% |
| 2013 | 0.00% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 15.00% | -100.05% |
US
|
|
| 18.08% | -100.06% |
IE
|
|
| 21.25% | -100.07% |
US
|
|
| 21.05% | -100.07% |
US
|
|
| 25.52% | -100.08% |
US
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Beyond Air, Inc.'s operating margin
What is Beyond Air, Inc.'s operating margin?
Beyond Air, Inc.'s operating margin is -321.65%, as of Nov 2026.
What was Beyond Air, Inc.'s operating margin in 2025?
In 2025, Beyond Air, Inc.'s operating margin was -1,202.08%, compared with -5,436.24% in 2024.
How has Beyond Air, Inc.'s operating margin changed since 2020?
From 2020 to 2025, Beyond Air, Inc.'s operating margin was highest in 2023 (0.00%) and lowest in 2024 (-5,436.24%).
How does Beyond Air, Inc.'s operating margin compare with similar companies?
Beyond Air, Inc.'s operating margin (-321.65%) is lower than that of all 5 similar companies listed above. The highest among them is Edwards Lifesciences Corporation, with 25.52%.